IRIS PubliCatt

Pagano, Livio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.502
NA - Nord America 8.045
AS - Asia 3.195
SA - Sud America 115
AF - Africa 43
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 19.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.949
DE - Germania 3.178
SE - Svezia 1.492
CN - Cina 1.483
SG - Singapore 921
IT - Italia 884
UA - Ucraina 813
IE - Irlanda 515
FR - Francia 430
ID - Indonesia 334
GB - Regno Unito 265
RU - Federazione Russa 243
FI - Finlandia 232
PL - Polonia 166
IN - India 144
TR - Turchia 109
BR - Brasile 77
NL - Olanda 56
CA - Canada 51
JP - Giappone 47
BE - Belgio 42
MX - Messico 38
HK - Hong Kong 37
AT - Austria 33
ES - Italia 32
RO - Romania 20
CI - Costa d'Avorio 19
CZ - Repubblica Ceca 19
IL - Israele 19
AU - Australia 16
CH - Svizzera 16
TH - Thailandia 13
VN - Vietnam 13
CL - Cile 11
LT - Lituania 11
AR - Argentina 9
IR - Iran 9
GR - Grecia 8
HU - Ungheria 8
KR - Corea 8
EU - Europa 7
SA - Arabia Saudita 7
DK - Danimarca 6
KZ - Kazakistan 6
PK - Pakistan 6
ZA - Sudafrica 6
CO - Colombia 5
LV - Lettonia 5
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
CR - Costa Rica 4
EC - Ecuador 4
HR - Croazia 4
JO - Giordania 4
MA - Marocco 4
MD - Moldavia 4
NG - Nigeria 4
PE - Perù 4
PH - Filippine 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BO - Bolivia 3
EG - Egitto 3
LA - Repubblica Popolare Democratica del Laos 3
ME - Montenegro 3
MY - Malesia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
AM - Armenia 2
ET - Etiopia 2
GH - Ghana 2
IQ - Iraq 2
KE - Kenya 2
LK - Sri Lanka 2
MK - Macedonia 2
PA - Panama 2
RS - Serbia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
EE - Estonia 1
IS - Islanda 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MT - Malta 1
NP - Nepal 1
PS - Palestinian Territory 1
SC - Seychelles 1
TJ - Tagikistan 1
Totale 19.927
Salva come PNG Salva come JPEG
Città #
Chandler 1.635
Singapore 660
Ashburn 588
Jacksonville 527
Dublin 508
San Mateo 403
Jakarta 333
Ann Arbor 312
Wilmington 282
Nanjing 277
Dearborn 219
Nürnberg 186
Milan 185
Woodbridge 182
Boston 181
Houston 177
Moscow 177
New York 173
Lawrence 170
Beijing 168
Bremen 158
Hangzhou 154
Warsaw 148
Cattolica 129
Zhengzhou 117
Munich 103
Princeton 103
Chicago 99
Nanchang 90
Redwood City 88
Rome 88
Marseille 87
Seattle 84
Fairfield 78
Izmir 77
Los Angeles 71
Boardman 69
Redmond 69
Mountain View 60
Shenyang 60
Hebei 58
Kunming 52
Shanghai 48
Tianjin 46
Lancaster 45
Norwalk 45
Changsha 44
University Park 43
Brussels 40
Nuremberg 39
Jiaxing 38
Hong Kong 34
Leawood 34
Cambridge 32
Guangzhou 32
Helsinki 32
Philadelphia 31
Washington 31
Toronto 27
Henderson 25
Paris 25
Auburn Hills 23
Falls Church 22
Fremont 22
Hefei 20
Pune 20
Andover 19
Cuauhtémoc 19
Falkenstein 19
Abidjan 18
Jinan 18
Busto Arsizio 17
Florence 17
Augusta 16
Tokyo 16
Frankfurt am Main 15
London 15
Phoenix 15
Edinburgh 14
Simi Valley 14
São Paulo 14
Mexico City 13
Vienna 13
Lappeenranta 12
Changchun 11
Costa Mesa 11
Council Bluffs 11
Indiana 11
Kraków 11
Monmouth Junction 11
Santa Clara 11
Madrid 10
Ningbo 10
Brno 9
Hanoi 9
Taizhou 9
Bern 8
Forest City 8
Kansas City 8
Modena 8
Totale 10.623
Salva come PNG Salva come JPEG
Nome #
Incidence of acute myeloid leukemia after breast cancer 336
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 312
Factors associated with mortality in bacteremic patients with haematologic malignancies 303
Factors associated with mortality in bacteremic patients with hematologic malignancies. 303
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 298
A prospective survey of febrile events in hematological malignancies 254
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 221
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 186
Factors associated with mortality in bacteremic patients with hematologic malignancies. 169
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 168
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 159
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 150
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 149
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 137
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 134
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 130
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 130
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 126
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 125
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 123
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 122
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 120
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 120
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 120
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 118
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 116
Primary plasma cell leukemia followed by testicular plasmacytoma 113
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 112
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 112
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 110
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 110
Epigenetic changes in therapy-related MDS/AML 109
Similarities and differences between therapy-related and elderly acute myeloid leukemia 108
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 108
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 107
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia 107
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 106
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 106
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 104
Hyperleukocytosis and leukostasis: management of a medical emergency 104
Hyperleukocytosis and leukostasis: management of a medical emergency 103
A prospective survey of febrile events in hematological malignancies 101
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. 100
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 100
A patient with acute myeloid leukemia and a solid mass in the colon. 99
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 99
A prospective survey of febrile events in hematological malignancies 99
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 99
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 99
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 96
Serum beta 2 microglobulin in psoriasis and psoriatic patients 96
Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection 96
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 96
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 95
Uncommon yeast infections in hematological patients: from diagnosis to treatment 95
Outcome of therapy-related myeloid neoplasms treated with azacitidine 95
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 94
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study 93
ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients 93
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 92
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 92
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 92
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 91
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 89
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 89
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 89
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 88
Advanced mast cell disease: an Italian Hematological Multicenter experience. 87
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 87
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients 87
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 87
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. 86
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 86
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 86
Tunneling Schmorl?s Nodes in an Elderly Woman Treated for Acute Lymphoblastic Leukemia. 85
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 85
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 84
In vitro susceptibility of Candida species isolated from patients with haematological malignancies 82
Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches 82
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 81
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 80
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 79
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 79
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 79
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 78
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 78
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 77
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 77
SEIFEM 2017: from real life to an agreement on the use of granulocyte transfusions and colony-stimulating factors for prophylaxis and treatment of infectious complications in patients with hematologic malignant disorders 77
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 76
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 73
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 73
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 72
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey 72
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 72
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 72
Retrospective Chart Review of Hospitalisations During Chemotherapy for Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) In Italy 71
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 70
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 70
The role of primary antifungal prophylaxis in patients with haematological malignancies 70
Totale 11.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.678
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020876 0 0 0 0 0 0 0 95 162 159 209 251
2020/20211.862 97 208 44 181 241 125 247 52 220 72 348 27
2021/20222.205 260 151 34 88 149 76 33 334 115 156 332 477
2022/20234.610 525 562 397 773 365 588 167 373 561 94 158 47
2023/20242.512 126 738 92 81 95 351 203 51 36 91 302 346
2024/20251.859 168 166 398 190 445 150 228 114 0 0 0 0
Totale 20.283